{"schema_version":"1","generated_at":"2026-10-28T15:06:00.425Z","data_as_of":null,"url":"https://www.findmykol.com/kol/thomas-beckham","json_url":"https://www.findmykol.com/kol/thomas-beckham/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"thomas-beckham","name":"Thomas Beckham","credential":"MD, PhD","title":"Associate Professor, Department of CNS - Rad Onc Clinical, Division of Radiation Oncology","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1043604457","orcid":"0000-0001-6189-6996","openalex":"A5081175661"},"summary":"Thomas Beckham is Associate Professor, Department of CNS - Rad Onc Clinical, Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 118 publications with 1,223 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":{"text":"Thomas Beckham, MD, PHD, is Associate Professor, Department of CNS - Rad Onc Clinical, Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center. The public record shows 118 publications with 1,238 citations (h-index 20), centered on Management of metastatic bone disease, Brain Metastases and Treatment, Glioma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies.","bullets":["Most recent indexed publication: 2026 · Journal of clinical oncology","Top research focus: Management of metastatic bone disease","2 registered trials on ClinicalTrials.gov","Open Payments reporting from 3 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"ST Elevation Myocardial Infarction","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Management of metastatic bone disease","Brain Metastases and Treatment","Glioma Diagnosis and Treatment","Spinal Fractures and Fixation Techniques","Advanced Radiotherapy Techniques"],"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"GT Medical Technologies, Inc","trials":0,"payments":17,"mentions":17},{"name":"M.D. Anderson Cancer Center","trials":2,"payments":0,"mentions":2},{"name":"Elekta, Inc.","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":118,"cited_by_count":1223,"h_index":20,"i10_index":26,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07655583","title":"OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy","status":"RECRUITING","role":"Investigator","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07655583","trial_url":"https://www.findmykol.com/trial/NCT07655583"},{"nct":"NCT06649058","title":"EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06649058","trial_url":"https://www.findmykol.com/trial/NCT06649058"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"GT Medical Technologies, Inc","program_year":2025,"amount_usd":1586.68,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043604457"},{"payer":"GT Medical Technologies, Inc","program_year":2024,"amount_usd":500,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043604457"},{"payer":"GT Medical Technologies, Inc","program_year":2023,"amount_usd":3028.54,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1043604457"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1043604457","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"congress":{"count":29,"years":{"first":2011,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO"],"shown":3,"withheld":26,"rows":[{"title":"Final results of a randomized, controlled, phase 3 trial comparing resection and post-operative stereotactic radiation versus resection and cesium-131 tile-based radiation for treatment of newly diagnosed brain metastases.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.17_suppl.lba2000","source_url":"https://doi.org/10.1200/jco.2026.44.17_suppl.lba2000","status":"verified"},{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco-26-01894","source_url":"https://doi.org/10.1200/jco-26-01894","status":"verified"},{"title":"Brain Metastases from Soft Tissue Sarcoma","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2025.06.2199","source_url":"https://doi.org/10.1016/j.ijrobp.2025.06.2199","status":"verified"}],"source":"congress"},"publications":{"total":5,"shown":5,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42804720/","status":"verified"},{"title":"[(18)F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade glioma.","year":2026,"journal":"Neuroradiology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41920333/","status":"verified"},{"title":"Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery.","year":2026,"journal":"Neuro-oncology advances","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41664820/","status":"verified"},{"title":"Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches.","year":2024,"journal":"Neuro-oncology practice","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38737610/","status":"verified"},{"title":"Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.","year":2020,"journal":"International journal of cancer","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/31609479/","status":"verified"}],"most_cited":{"total":118,"shown":5,"withheld":113,"rows":[{"title":"Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer","year":2008,"cited_by_count":120,"type":"article","source_url":"https://doi.org/10.1038/mt.2008.281"},{"title":"Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse","year":2013,"cited_by_count":118,"type":"article","source_url":"https://doi.org/10.1172/jci64791"},{"title":"Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy","year":2009,"cited_by_count":79,"type":"article","source_url":"https://doi.org/10.1517/14728220903357512"},{"title":"Acid ceramidase‐mediated production of sphingosine 1‐phosphate promotes prostate cancer invasion through upregulation of cathepsin B","year":2012,"cited_by_count":70,"type":"article","source_url":"https://doi.org/10.1002/ijc.27480"},{"title":"Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy","year":2023,"cited_by_count":67,"type":"review","source_url":"https://doi.org/10.3389/fonc.2023.1137849"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Amol Jitendra Ghia","coauthored_works":48},{"name":"Debra Nana Yeboa","coauthored_works":47},{"name":"Martin C. Tom","coauthored_works":45}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":5,"shown":5,"rows":[{"value":"American Board of Radiology: Diplomate of Radiation Oncology (2020)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"American Board of Radiology: Initial Certification, Physics and Radiation Biology (2019)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"MD, Medical University of South Carolina (2015)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"PhD, Molecular Biology, Medical University of South Carolina (2015)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"BS, Genetics, Clemson University (2007)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"}]},"roles":{"total":9,"shown":3,"rows":[{"value":"Cancer Neurosciences Program Neural Neoplasm Director (2025-present)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"Member, Society for Neuro-Oncology (2023-present)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"CNS Residency Education Director, Radiation Oncology (2023-present)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Best Young Investigator Award for the Americas, Leksell Gamma Knife Society (2025-present)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"},{"value":"Alpha Omega Alpha, Medical University of South Carolina (2014)","source_url":"https://faculty.mdanderson.org/profiles/thomas_beckham.html","status":"verified","collected_at":"2026-10-27"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Memorial Sloan Kettering Cancer Center","source_url":"https://orcid.org/0000-0001-6189-6996","status":"verified","collected_at":"2026-10-27"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Presenter, \"Brain Metastases in Melanoma\" program, September 24, 2026 (AIM at Melanoma)","source_url":"https://www.aimatmelanoma.org/melanoma-learning-center/symposiums-2/md-anderson-cancer-center-september-24-2026/","status":"verified","collected_at":"2026-10-27"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Principal investigator, EXCLAIM phase II trial in low-risk brain metastases (NCT06649058)","source_url":"https://clinicaltrials.gov/study/NCT06649058","status":"provisional","collected_at":"2026-10-27"}]}},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"77030-4000","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1043604457","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"congress":26,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-02-25","provider_certified":"2021-02-25","collected_at":"2026-07-28"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-27"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-27"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward","collected_at":"2026-10-27"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-27"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-27"}},"methodology_url":"https://www.findmykol.com/about#methodology"}